Chronic kidney disease trials in Saudi Arabia
2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Al-Ahsa, Dammam, Riyadh, Riyadh/MENA
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 2Taking peopleSafety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
- Where
- Riyadh
- Age
- 12 years to 18 years
- People
- 18 worldwide
- Run by
- Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00